United States Polypeptide Drug Market Research Report Forecast 2017-2022

April 2017 | 116 pages | ID: UADD2A44730EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Polypeptide Drug Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Polypeptide Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Polypeptide Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda

United States Polypeptide Drug Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Polypeptide Drug Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 POLYPEPTIDE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Polypeptide Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of Polypeptide Drug by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Polypeptide Drug Market Segmentation by Application
  1.3.1 Polypeptide Drug Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Polypeptide Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON POLYPEPTIDE DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES POLYPEPTIDE DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States Polypeptide Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States Polypeptide Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Polypeptide Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Polypeptide Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Polypeptide Drug Market Competitive Situation and Trends
  3.5.1 Polypeptide Drug Market Concentration Rate
  3.5.2 Polypeptide Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES POLYPEPTIDE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Polypeptide Drug Production and Market Share by Type (2012-2017)
4.2 United States Polypeptide Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Polypeptide Drug Price by Type (2012-2017)
4.4 United States Polypeptide Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES POLYPEPTIDE DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States Polypeptide Drug Consumption and Market Share by Application (2012-2017)
5.2 United States Polypeptide Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES POLYPEPTIDE DRUG MANUFACTURERS ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Merck Serono
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Ferring Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Ipsen PHarma Biotech
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Lilly
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Asahi Kasei
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 AstraZeneca
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 SciClone Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Takeda
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

7.1 Polypeptide Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polypeptide Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polypeptide Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

11.1 United States Polypeptide Drug Production, Revenue Forecast (2017-2022)
11.2 United States Polypeptide Drug Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Polypeptide Drug Production Forecast by Type (2017-2022)
11.4 United States Polypeptide Drug Consumption Forecast by Application (2017-2022)
11.5 Polypeptide Drug Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure United States Sales Market Share of Polypeptide Drug by Type in 2016
Table Application of Polypeptide Drug
Figure United States Sales Market Share of Polypeptide Drug by Application in 2016
Figure United States Polypeptide Drug Sales and Growth Rate (2011-2021)
Figure United States Polypeptide Drug Revenue and Growth Rate (2011-2021)
Table United States Polypeptide Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Polypeptide Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table United States Polypeptide Drug Revenue by Manufacturers (2015 and 2016)
Table United States Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Polypeptide Drug Revenue Share by Manufacturers
Table 2016 United States Polypeptide Drug Revenue Share by Manufacturers
Table United States Market Polypeptide Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Polypeptide Drug Average Price of Key Manufacturers in 2015
Figure Polypeptide Drug Market Share of Top 3 Manufacturers
Figure Polypeptide Drug Market Share of Top 5 Manufacturers
Table United States Polypeptide Drug Sales by Type (2012-2017)
Table United States Polypeptide Drug Sales Share by Type (2012-2017)
Figure United States Polypeptide Drug Sales Market Share by Type in 2015
Table United States Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table United States Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Table United States Polypeptide Drug Price by Type (2012-2017)
Figure United States Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table United States Polypeptide Drug Sales by Application (2012-2017)
Table United States Polypeptide Drug Sales Market Share by Application (2012-2017)
Figure United States Polypeptide Drug Sales Market Share by Application in 2016
Table United States Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Figure United States Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Polypeptide Drug Market Share (2012-2017)
Table Merck Serono Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Serono Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Polypeptide Drug Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ferring Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Pharmaceuticals Polypeptide Drug Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ipsen PHarma Biotech Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Ipsen PHarma Biotech Polypeptide Drug Market Share (2012-2017)
Table Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lilly Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Lilly Polypeptide Drug Market Share (2012-2017)
Table Asahi Kasei Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Asahi Kasei Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Asahi Kasei Polypeptide Drug Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Polypeptide Drug Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SciClone Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table SciClone Pharmaceuticals Polypeptide Drug Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Takeda Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Polypeptide Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure United States Polypeptide Drug Production and Growth Rate Forecast (2017-2022)
Figure United States Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States Polypeptide Drug Production Forecast by Type (2017-2022)
Table United States Polypeptide Drug Consumption Forecast by Application (2017-2022)